Create
Log in
Enquire now
Dmitry Suzko
Bachelor in medicine Qualified sales
Joined February 2022
512
Contributions
Contributions
Activity
Gyo Sagara
was edited by
Dmitry Suzko
June 15, 2022 10:29 pm
Infobox
CEO of
0
Current Employer
0
Location
0
Jean-Claude Dubacher
was edited by
Dmitry Suzko
June 15, 2022 10:28 pm
Infobox
CEO of
0
Current Employer
0
Educated at
0
0
Founder of
0
Location
0
Ajay K Singh
was edited by
Dmitry Suzko
June 15, 2022 10:26 pm
Infobox
CEO of
0
Current Employer
0
Educated at
0
0
Founder of
0
Location
0
James C. Gale
was edited by
Dmitry Suzko
June 15, 2022 10:24 pm
Infobox
Educated at
0
Founder of
0
Location
0
Gaurav Mehrotra
was edited by
Dmitry Suzko
June 15, 2022 10:22 pm
Infobox
CFO of
0
Educated at
0
0
Location
0
Venkat Krishnan
was edited by
Dmitry Suzko
June 15, 2022 10:20 pm
Infobox
CEO of
0
Educated at
0
Founder of
0
Location
0
Bryan Walser
was edited by
Dmitry Suzko
June 15, 2022 10:17 pm
Infobox
CEO of
0
Educated at
0
0
0
0
0
Founder of
Aimmune Therapeutics
0
Bruce A. Peacock
was edited by
Dmitry Suzko
June 15, 2022 10:12 pm
Infobox
Founder of
Interius BioTherapeutics
0
Interius BioTherapeutics Series A May 18, 2021
was edited by
Dmitry Suzko
June 3, 2022 11:22 pm
Infobox
Announcement URL
https://www.crunchbase.com/funding_round/interius-biotherapeutics-series-a--c3ff6ea7
Funded company
Interius BioTherapeutics
Funding round date
May 18, 2021
Funding round amount (USD)
76,000,000
Funding type
Series A
Investment
Cormorant Asset Management
Fairmount Funds Management
Interius BioTherapeutics Series A May 18, 2021
was created by
Dmitry Suzko
"Created via: Web app"
June 3, 2022 11:20 pm
Interius BioTherapeutics Series A May 18, 2021
Interius BioTherapeutics Venture Round Mar 13, 2020
was edited by
Dmitry Suzko
June 3, 2022 11:19 pm
Infobox
Announcement URL
https://www.crunchbase.com/funding_round/interius-biotherapeutics-series-unknown--f005af9c
Funded company
Interius BioTherapeutics
Funding round date
March 13, 2020
Funding round amount (USD)
5,500,000
Funding type
Venture round
Investment
Agent Capital
Geeta Vemuri
Bruce A. Peacock
Interius BioTherapeutics Venture Round Mar 13, 2020
was created by
Dmitry Suzko
"Created via: Web app"
June 3, 2022 11:17 pm
Interius BioTherapeutics Venture Round Mar 13, 2020
Bruce A. Peacock
was edited by
Dmitry Suzko
June 3, 2022 11:16 pm
Bruce A. Peacock
Infobox
LinkedIn URL
https://www.linkedin.com/in/bruce-peacock-3280777/
Location
Baltimore
Occupation
Investor
Venture Partner
Interius BioTherapeutics
was edited by
Dmitry Suzko
June 3, 2022 11:15 pm
Interius BioTherapeutics
Novel methods for in vivo cell-specific gene delivery
Infobox
Legal name
Interius BioTherapeutics, Inc.
Company Operating Status
Active
Competitors
Amicus Therapeutics
TARIS Biomedical
Crunchbase
https://www.crunchbase.com/organization/interius-biotherapeutics
Email address
info@interiusbio.com
0
Founded date
2019
Founder
Bruce A. Peacock
Full address
3401 Grays Ferry Avenue Building 200, Suite 300 Philadelphia, PA 19146
0
Industry
Biopharmaceutical
Therapeutics
LinkedIn URL
https://www.linkedin.com/company/interius-biotherapeutics/about/
Location
Philadelphia
Number of Employees (ranges)
20 – 49
0
Phone number
215.608.9333
610-639-4644
Aimmune Therapeutics
was edited by
Dmitry Suzko
June 3, 2022 11:08 pm
Infobox
Crunchbase
https://www.crunchbase.com/organization/allergen-research-corporation
Aimmune Therapeutics Series B Mar 12, 2015
was edited by
Dmitry Suzko
June 3, 2022 11:07 pm
Infobox
Announcement URL
https://www.crunchbase.com/funding_round/allergen-research-corporation-series-b--5ccb2e35
Funded company
Aimmune Therapeutics
Funding round date
March 12, 2015
Funding round amount (USD)
80,000,000
Funding type
Series B
Investment
Foresite Capital
0
Longitude Capital
Patrick Enright
Aimmune Therapeutics Series B Mar 12, 2015
was created by
Dmitry Suzko
"Created via: Web app"
June 3, 2022 11:05 pm
Aimmune Therapeutics Series B Mar 12, 2015
Bryan Walser
was edited by
Dmitry Suzko
June 3, 2022 11:04 pm
Bryan Walser
Infobox
Founder of
Aimmune Therapeutics
Occupation
Investor
Aimmune Therapeutics
was edited by
Dmitry Suzko
June 3, 2022 11:01 pm
Aimmune Therapeutics
Food allergy therapies
Infobox
Website URL
http://aimmune.com
Acquirer
Nestle Health Science
Legal name
Aimmune Therapeutics, Inc.
Company Operating Status
Active
Competitors
Aclaris Therapeutics
Interius BioTherapeutics
Email address
corporatedevelopment@aimmune.com
0
hr@aimmune.com
media@aimmune.com
Founded date
2011
Industry
Healthcare
Therapeutics
Number of Employees (ranges)
250 – 499
Phone number
(650)614-5220
Exchange
Nasdaq
Stock symbol
AIMT
Alpine Immune Sciences Seed Round Jun 23, 2015
was edited by
Dmitry Suzko
June 3, 2022 10:54 pm
Infobox
Announcement URL
https://www.crunchbase.com/funding_round/alpine-immune-sciences-seed--b3c230a4
Funded company
Alpine Immune Sciences
Funding round date
January 23, 2015
Funding round amount (USD)
1,300,000
Funding type
Seed
Load more